局部应用氨甲环酸对关节软骨有毒性吗?安全剂量是多少?
该研究在二维和三维模型中分析人软骨细胞暴露于不同浓度(0至40 mg/ml)和时长(0至12小时)氨甲环酸后的形态、黏附、代谢活性和活力,并在关节软骨活样本中确认。结果显示浓度高于20 mg/ml时出现细胞形态异常、黏附与代谢活性降低及软骨细胞死亡增加,但细胞基质未受影响;结论认为推荐关节腔内给药后的浓度可观察到细胞毒性,10 mg/ml至20 mg/ml的组织浓度可望安全。
要点
- 氨甲环酸浓度高于20 mg/ml时,人软骨细胞出现非典型形态、黏附与代谢活性降低及死亡增加。
- 细胞基质不受氨甲环酸浓度或暴露时长影响,并对低于20 mg/ml的浓度提供细胞保护。
- 作者结论认为10 mg/ml至20 mg/ml的组织浓度可望安全。
核心结论
- 体外软骨细胞暴露于较高浓度氨甲环酸(如推荐关节腔内给药后预期浓度)时观察到细胞毒性,该效应呈剂量依赖性。
- 作者结论认为10 mg/ml至20 mg/ml的组织浓度可望安全。
研究设计与样本
- 研究在二维模型中分析人软骨细胞随氨甲环酸浓度递增(0 mg/ml至40 mg/ml)和暴露时间延长(0至12小时)的细胞形态、黏附、代谢活性和活力。
- 随后在三维模型中重复上述分析(不包括细胞黏附),并在关节软骨活样本中确认。
主要发现
- 氨甲环酸浓度高于20 mg/ml导致非典型形态、细胞黏附降低和代谢活性降低,并伴有软骨细胞死亡增加。
- 细胞基质不受氨甲环酸浓度或暴露时长影响,并对低于20 mg/ml的浓度提供细胞保护。
临床怎么用
- 作者结论认为10 mg/ml至20 mg/ml的组织浓度可望安全。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIMS: The intra-articular administration of tranexamic acid (TXA) has been shown to be effective in reducing blood loss in unicompartmental knee arthroplasty and anterior cruciate reconstruction. The effects on human articular cartilage, however, remains unknown. Our aim, in this study, was to investigate any detrimental effect of TXA on chondrocytes, and to establish if there was a safe dose for its use in clinical practice. The hypothesis was that TXA would cause a dose-dependent damage to human articular cartilage. MATERIALS AND METHODS: The cellular morphology, adhesion, metabolic activity, and viability of human chondrocytes when increasing the concentration (0 mg/ml to 40 mg/ml) and length of exposure to TXA (0 to 12 hours) were analyzed in a 2D model. This was then repeated, excluding cellular adhesion, in a 3D model and confirmed in viable samples of articular cartilage. RESULTS: Increasing concentrations above 20 mg/ml resulted in atypical morphology, reduced cellular adhesion and metabolic activity associated with increased chondrocyte death. However, the cell matrix was not affected by the concentration of TXA or the length of exposure, and offered cellular protection for concentrations below 20 mg/ml. CONCLUSION: These results show that when in vitro chondrocytes are exposed to higher concentrations of TXA, such as that expected following recommended intra-articular administration, cytotoxicity is observed. This effect is dose-dependent, such that a tissue concentration of 10 mg/ml to 20 mg/ml could be expected to be safe. Cite this article: Bone Joint J 2018;100-B:404-12.
引用
- Parker JD, Lim KS, Kieser DC, et al. Is tranexamic acid toxic to articular cartilage when administered topically? What is the safe dose? Bone Joint J. 2018. PMID: 29589496. doi:10.1302/0301-620X.100B3.BJJ-2017-1135.R1
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。